Abstract
Get full access to this article
View all access options for this article.
References
1.
www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/history
[accessed November 1, 2022]
2.
www.fda.gov/medical-devices/ivd-regulatory-assistance/overview-ivd-regulation
[accessed November 1, 2022]
3.
www.tecan.com/blog/how-to-navigate-the-ivdd-ivdr-transition-part-1
[accessed November 1, 2022]
4.
qbdgroup.com/en/blog/ivdr-classification-of-in-vitro-diagnostic-medical-devices-guide
[accessed November 1, 2022]
5.
health.ec.europa.eu/system/files/2022-01/md_mdcg_2020_guidance_classification_ivd-md_en.pdf
[accessed November 1, 2022]
6.
Carter
LL
,
Yu
MA
,
Sacks
MA
et al. Bull World Health Organ , 2022 ; 100 (4 ): 239 –239A .
7.
www.england.nhs.uk/long-read/accelerating-genomic-medicine-in-the-nhs
[accessed November 1, 2022]